Radiation enhancement by 9-Aminocamptothecin. Evidence for improved therapeutic ratio with a multiple dose schedule

Annals of the New York Academy of Sciences

Volumn 803, Issue , 1996, Pages 312-314

  Kirichenko, A V ^a   Travis, E L ^a   Rich, T A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 AMINOCAMPTOTHECIN; ANTINEOPLASTIC ALKALOID;

ANIMAL EXPERIMENT; BREAST CARCINOMA; CONFERENCE PAPER; EXPERIMENTAL NEOPLASM; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; IRRADIATION; MOUSE; NONHUMAN;

EID: 0030464703     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb26403.x     Document Type: Conference Paper

References (5)

1. BOOTHMAN, D. A., N. FUKUNADA & M. WANG. 1994. Down-regulation of topoisomerase 1 in mammalian cells following ionizing radiation. Cancer Res. 54: 4618-4626.
2. KIM, J. H., S. H. KIM, A. KOLOZSVARY & M. KHIL. 1992. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan. Int. J. Radiat. Oncol. Biol. Phys. 22: 515-518.
3. BOSCIA, R. E., T. KORBUT, S. A. HOLDEN, G. ARA & B. A. TEICHER. 1993. Interaction of topoisomerase 1 inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FASTS fibrosarcoma in vivo. Int. J. Cancer 53: 118-123.
4. SLICHENMYER, W. J., E. K. ROWINSKY, R. C. DONEHOWER & S. H. KAUFMANN. 1993. The current status of camptothecin analogues as antitumor agents. J. Natl. Cancer Inst. 85: 273-291.
5. HOUGHTON, P. J., P. J. CHESHIRE, J. D. HALLMAN, L. LUTZ, H. S. FRIEDMAN, M. K. DANKS & J. A. HOUGHTON. 1995. Efficacy of topoisomerase 1 inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother. & Pharmacol. 36: 393-403.